MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Evaluation of ocular perfusion in Parkinson’s disease and association with clinical manifestations.

    A. Camacho-Ordonez, M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Hernández-Medrano, O. Guerrero-Berger (Mexico, Mexico)

    Objective: To evaluate optic nerve head and macular perfusion in subjects with Parkinson's disease (PD) and its association with clinical manifestations. Background: PD is associated…
  • 2022 International Congress

    COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, S. Umutbaev, O. Kachemaeva, A. Baitimerov, R. Galimova, R. Magzhanov (Ufa, Russian Federation)

    Objective: We examined the influence of single nucleotide polymorphisms (SNPs) in specific genes on levodopa-induced dyskinesia development in Parkinson’s disease patients Background: Levodopa-induced dyskinesia (LID)…
  • 2022 International Congress

    Gait declines faster over time in people with Parkinson’s disease converting to a freezing of gait phenotype

    T. Virmani, A. Glover, L. Pillai (Little Rock, USA)

    Objective: To monitor gait progression in people with Parkinson’s disease (PwPD) who convert from a non-freezing (noFOG) to a freezing of gait (FOG) phenotype. Background:…
  • 2022 International Congress

    Screening of REM Sleep Behavior Disorder and the relation with parkinsonism symptoms in the elderly in southern Brazil: a preliminary population-based study

    G. Pereira, N. Soares, E. Moriguchi, J. Senger, M. Sartori, N. Bruscato, C. Bertocchi, L. Netson, R. Almeida, A. Schumacher-Schuh, C. Rieder (Porto Alegre, Brazil)

    Objective: To describe the preliminary screening profile for suspected REM sleep behavior disorders (RBD) and association with parkinsonian symptoms in the elderly in a population-based…
  • 2022 International Congress

    Machine Learning and Instrumented Gait Analysis to Classify Subthalamic DBS States in Parkinson’s Disease

    J. Watts, A. Khojandi, R. Ramdhani (Knoxville, USA)

    Objective: This study investigates whether gait features derived from an instrumented walk can predict specific treatment conditions (stimulation frequency and medication status)  in a cohort…
  • 2022 International Congress

    Effect of freezing of gait on the neural activity during the cognitive-motor conflict in step initiation in individuals with Parkinson’s disease: a case study

    L. de Oliveira, C. de Oliveira, P. Bazán, C. Bernardo, E. Los Angeles, M. Carvalho, J. Sato, A. de Lima-Pardini, D. Coelhodaniel, A. Baptista (Diadema, Brazil)

    Objective: To analyze the effect of freezing of gait (FoG) on the hemodynamic responses of the supplementary motor area (SMA) and dorsolateral prefrontal cortex (DLPFC)…
  • 2022 International Congress

    A longitudinal evaluation of the peripheral immune phenotype in a cohort of Parkinson’s disease patients

    L. Magistrelli, A. Furgiuele, E. Contaldi, M. Legnaro, E. Rasini, C. Comi, F. Marino, M. Cosentino (Novara, Italy)

    Objective: To evaluate the suitable modifications of immunological parameters in a through characterized population of Italian PD patientsTo evaluate the suitable modifications of immunological parameters…
  • 2022 International Congress

    Levodopa-carbidopa intestinal gel infusion and long-term tolerability in Parkinson’s: multicentre, international 13-year follow-up data

    V. Leta, L. Batzu, L. Williams, S. Waller, F. Garri, K. Rukavina, M. Parry, S. Jones, J. Griffith, N. Jeyakumar, M. Scharfenort, P. Odin, V. Metta, G. Chung-Faye, P. Dubois, T. Marshall, A. Zecchinelli, F. Del Sorbo, V. Viljaharju, E. Pekkonen, A. Antonini, V. Fung, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To evaluate the long-term range and nature of Levodopa-carbidopa intestinal gel (LCIG) infusion-related complications in people with Parkinson’s (PwP). Background: LCIG infusion is an…
  • 2022 International Congress

    Comparison of Voice, Speech, Swallowing and Drooling Problems in Parkinson’s Disease Patients with Healthy Individuals

    M. Sapmaz Atalar, G. Genç, ş. Oğur (Istanbul, Turkey)

    Objective: To compare voice, speech, swallowing and drooling problems in Parkinson's disease (PD) patients with healthy individuals (HI) by using objective and subjective methods and…
  • 2022 International Congress

    Secondary generalized myoclonus resulting from brainstem ischemic lesion

    S. Saaf, A. Miqdadi, S. Lhassani, M. Hakimi, J. Aasfara, A. Hazim (Casablanca, Morocco)

    Objective: To report the case of a patient who developed generalized myoclonus revealing ischemic lesions of the brainstem Background: Myoclonus is a movement disorder defined…
  • « Previous Page
  • 1
  • …
  • 681
  • 682
  • 683
  • 684
  • 685
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley